PrimeX News

US Dollar Price Forecast: DXY Retests $101 on Triangle Breakout — Will GBP/USD and EUR/USD Break?
Thu, 25 Jun 2026 06:46:49 GMT
Gold vs. Bitcoin: BTC Price Tests $60,000 as Bear Flag Pressure Builds
Thu, 25 Jun 2026 06:33:51 GMT
Gold (XAUUSD) & Silver Price Forecast: Gold Breaks $3,980 as Silver Dives to $57 Amid Ceasefire — Bearish Turn?
Thu, 25 Jun 2026 06:27:09 GMT
Natural Gas and Oil Forecast: WTI Under $70 While Brent Tests $73 — NatGas Channel Momentum?
Thu, 25 Jun 2026 06:13:19 GMT
Nasdaq Index: Micron’s AI Outlook Ends Chip Selloff, Lifts Tech Stocks
Thu, 25 Jun 2026 07:13:18 GMT
Oil News: Crude Oil Outlook Sours as Physical Discounts Spread Globally
Thu, 25 Jun 2026 06:03:55 GMT

First Light News: Trump Puts Pen to Paper & the Fed Comes in Hawkish
Thu, 18 Jun 2026 08:20:37 GMT
ECB, Bank of England Set to Hold Rates Unchanged Today
Thu, 11 Jun 2026 17:21:35 GMT
Nasdaq 100: Meta Falls as Amazon Slips, Microsoft, Alphabet Diverge
Wed, 29 Apr 2026 21:43:04 GMT
Hungary’s Euro Ambition Is a Long-term Bet Requiring Discipline, Credibility and Integration
Thu, 11 Jun 2026 17:22:50 GMT
A Divided Fed to Continue Favouring Easing Even as the Iran War Raises the Stakes
Thu, 11 Jun 2026 17:20:25 GMT
ECB Policy to Ultimately Be Determined by the Fallout from the Iran War
Thu, 11 Jun 2026 17:22:12 GMT

Seasonality and Event-Driven Trades in ETFs: How to Spot Recurring Trading Opportunities
Fri, 19 Jun 2026 23:26:11 GMT
Building and Risk-Managing Multi-Asset Portfolios with ETFs
Fri, 19 Jun 2026 20:08:58 GMT
What Really Drives ETF Performance: Rebalancing, Dividends, Fees, and Tracking Error
Tue, 23 Jun 2026 13:26:26 GMT
Trading Volume Explained: Why it Matters for Breakouts, Reversals and Trends
Wed, 10 Jun 2026 00:40:01 GMT
RSI Indicator Explained: How to Read Momentum and Time Trades in 2026
Wed, 03 Jun 2026 21:56:39 GMT
Fibonacci Retracements Explained: How to Spot Key Reversal Levels in 2026
Thu, 28 May 2026 12:22:53 GMT

Advertisement

Advertisement

ATHE

Alterity Therapeutics Limited - ADR

5.07

USD

+0.11

+2.12%

Jun 24, 15:22 UTC -4

Closed

exchange

After-Market

5.05

-0.01

-0.20%

ATHE News & Forecasts

featured

Alterity Therapeutics Advances Lead Drug Towards Pivotal Study For Rare Neuromuscular Disorder

featured

Alterity Therapeutics Limited (ATHE) Discusses Phase II Data and Development Strategy for ATH434 in Multiple System Atrophy Transcript

Advertisement

Advertisement

Advertisement